MTR and female reproductive organ cancer: Analysis of the dataset of gynecologic cancers and controls revealed synergistic interactions between MTHFD1 rs2236225 and MTHFR rs1801133 (IG = 0.06%) and MTHFR rs1801133 and MTR rs1805087 (IG = 0.08%).